Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery
- PMID: 35711284
- PMCID: PMC9197661
- DOI: 10.1155/2022/1951014
Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery
Abstract
Cataract surgery is widespread. The surgical procedure is associated with damage to the epithelial barrier and interruption of the corneal innervation. In addition, pathological events sustain signs and symptoms that may persist for a long time. Recently, a fixed combination of alpha-glycerylphosphorylcholine and D-Panthenol (Oftassiale) has been available as eye drops. The present study investigated the effects of an Oftassiale therapy in 20 patients undergoing cataract surgery. A comparison group included 20 patients treated with topical hyaluronic acid. Standard prophylactic and anti-inflammatory treatment was prescribed to all patients. Clinical signs and symptoms were assessed over time. In vivo confocal microscopy (IVCM) was performed accordingly. Oftassiale treatment significantly reduced clinical features and improved IVCM outcomes. In addition, therapy was well-tolerated, and no clinically significant adverse events occurred. In conclusion, this study confirmed that IVCM helps assess the tunnel after cataract surgery due to its ability to provide microscopic details in vivo. Topical therapy with alpha-glycerylphosphorylcholine and D-Panthenol eye drops promoted and stabilized the reepithelialization process. This fixed combination also accelerated and modulated the repair of the corneal innervation. Moreover, this treatment was well-tolerated and safe.
Copyright © 2022 Gianluca Martone et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures




Similar articles
-
In vivo and ex vivo evaluation of cell-cell interactions, adhesion and migration in ocular surface of patients undergone excimer laser refractive surgery after topical therapy with different lubricant eyedrops.Int Ophthalmol. 2018 Aug;38(4):1591-1599. doi: 10.1007/s10792-017-0627-y. Epub 2017 Jul 4. Int Ophthalmol. 2018. PMID: 28676989
-
State of the art clinical efficacy and safety evaluation of N-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases.Curr Clin Pharmacol. 2009 Jan;4(1):4-37. doi: 10.2174/157488409787236074. Curr Clin Pharmacol. 2009. PMID: 19149498 Clinical Trial.
-
Effect of D-Panthenol on Corneal Epithelial Healing after Surface Laser Ablation.J Ophthalmol. 2018 Nov 12;2018:6537413. doi: 10.1155/2018/6537413. eCollection 2018. J Ophthalmol. 2018. PMID: 30538855 Free PMC article.
-
Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique.Recent Pat Drug Deliv Formul. 2016;10(2):82-129. doi: 10.2174/1872211309666150618104657. Recent Pat Drug Deliv Formul. 2016. PMID: 26084629 Review.
-
Topical anaesthesia plus intracameral lidocaine versus topical anaesthesia alone for phacoemulsification cataract surgery in adults.Cochrane Database Syst Rev. 2020 Jul 28;7(7):CD005276. doi: 10.1002/14651858.CD005276.pub4. Cochrane Database Syst Rev. 2020. PMID: 35658539 Free PMC article. Review.
Cited by
-
Choline supplements: An update.Front Endocrinol (Lausanne). 2023 Mar 7;14:1148166. doi: 10.3389/fendo.2023.1148166. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36950691 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources